CEO John Lewis chatted with Kevin Folta of the Talking Biotech Podcast, a weekly podcast that uncovers the stories, ideas, and research of people at the frontier of biology and engineering.
Listen to their insightful conversation about the advantages using lipid nanoparticles (LNPs) for drug delivery along with the promise of Entos’ Fusogenix Proteolipid Vehicle (PLV) technology. The podcast is available on Apple Podcasts, Google Podcasts, and Spotify, and you can also listen at the link below. Enjoy!